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Mild MPP+ exposure-induced 
glucose starvation enhances 
autophagosome synthesis and 
impairs its degradation
Shuichiro Sakamoto1, Masatsugu Miyara1,2, Seigo Sanoh1, Shigeru Ohta1 & Yaichiro Kotake1
Parkinson’s disease (PD) is a prevalent neurodegenerative disorder, mainly characterised by the 
progressive loss of dopaminergic neurons. MPP+ has been widely used as a PD-related neurotoxin, 
and their reports suggested the several hypotheses for neuronal cell death. However, most of these 
hypotheses come from the studies about the acute MPP+ exposure. We previously revealed that 
mild MPP+ exposure (10 and 200 μM), which induces gradual cell death, impairs autophagosome 
degradation at 48 h. In the present study, we further investigated the specific events of mild MPP+ 
exposure and revealed that mild MPP+ exposure causes the cell death through glucose starvation, but 
not acute toxic model (2.5 and 5 mM). At 36 h after mild MPP+ exposure, autophagosome synthesis 
was enhanced owing to glucose starvation and continued to enhance until 48 h, despite impaired 
autophagosome degradation. Inhibition of autophagosome synthesis reduced mild MPP+-induced cell 
death. In conclusion, we clarified that glucose starvation-enhanced autophagosome synthesis occurs at 
an earlier stage than impaired autophagosome degradation and is important in mild MPP+ toxicity.
Parkinson’s disease (PD) is the second most common neurodegenerative movement disorder characterised by 
resting tremor, slowness of movement, postural instability and muscle rigidity. The most prominent pathological 
features of PD are the loss of dopaminergic neurons in the substantia nigra pars compacta and the appearance of 
protein inclusions, known as Lewy bodies.
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), known to induce irreversible motor abnormalities 
in humans and primates, has been extensively studied as an etiologic model of PD. The neurotoxic effects of 
MPTP are attributable to its metabolite 1-methyl-4-phenylpyridinium (MPP+), which is formed by monoamine 
oxidase B-mediated oxidation1,2. Several MPTP administration protocols have been proposed to produce mouse 
models of PD, including acute, sub-chronic and chronic treatments3. In acute and sub-chronic models, dopa-
minergic neurons have been shown to die quickly, with little progression in the loss of nigrostriatal dopamine. 
Furthermore, inclusion bodies are not found in the remaining dopaminergic neurons3. Several chronic MPTP 
mouse models have been developed to replicate the slow progression of PD and have exhibited slower decreases 
in dopaminergic cell numbers as well as the formation of inclusion bodies3–6. Therefore, a chronic MPTP admin-
istration protocol would more suitably replicate the nature of PD.
Many cell-based studies on the mechanism underlying MPP+ toxicity have suggested several hypotheses for 
neuronal cell death, including respiration deficit, energy failure, calcium homeostasis dysregulation, excitatory 
input, oxidative stress and apoptosis execution7. However, most studies supporting these hypotheses performed 
with acute MPP+ exposure to induce adverse effects within 24 h; therefore, the toxicity of mild MPP+ exposure 
remains controversial. In our previous report, we developed a mild MPP+ exposure model that might more 
appropriately replicate PD pathology8. In brief, SH-SY5Y human neuroblastoma cells were exposed to low con-
centrations of MPP+ (10 and 200 μ M) for 48 h. Exposure to 10 μ M MPP+ for 48 h induced the accumulation of 
α -synuclein (α -syn), a major component of Lewy bodies. In the present study, we discovered that mild MPP+ 
exposure induced glucose starvation, leading to cell death, whereas acute MPP+ exposure (2.5 and 5 mM for 24 h) 
did not. Therefore, we investigated the mechanism underlying the specific toxicity of mild MPP+.
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Results
The toxic effects of mild MPP+ exposure are distinct compared with those of acute MPP+ expo-
sure. In our previous report, we used 10 and 200 μ M MPP+ for mild exposure models and 2.5 and 5 mM MPP+ 
for acute toxic exposure models8. To validate the utility of the former, we further evaluated differences between 
the two models. SH-SY5Y were exposed to predetermined concentrations of MPP+ for up to 24 h or 48 h, after 
which cell viabilities were evaluated using the WST-1 assay. A time course analysis revealed that exposure to 10 
and 200 μ M MPP+ significantly decreased cell viability after 48 h but not within 36 h (Fig. 1a), whereas expo-
sure to 2.5 and 5 mM MPP+ decreased cell viability within 6 h in a manner that appeared to be time dependent 
(Fig. 1b).
We further sought to elucidate differences in toxicity between the two models; the toxicity in the mild MPP+ 
exposure model significantly increased in a cell density-dependent manner, whereas that in the acute toxic expo-
sure model did not (Fig. 1c,d).
Mild MPP+, but not acute toxic, exposure induces glucose starvation, leading to cell death. 
Because a higher cell density expedited cell death only under mild MPP+ exposure, we hypothesised that the 
difference in toxicity between the mild and acute MPP+ exposure models stemmed from the rate of consumption 
of a particular nutrient in the culture medium. MPP+ inhibits mitochondrial oxidative phosphorylation by inhib-
iting complex I of the mitochondrial electron transport chain (ETC)9, thereby facilitating anaerobic glycolysis10. 
Therefore, we evaluated the effects of mild and acute MPP+ exposures on glycolytic activity. First, we measured 
the amount of glucose in the culture medium; the exposure to 10 and 200 μ M MPP+ resulted in significant reduc-
tions in extracellular glucose levels within 36 and 24 h, respectively (Fig. 2a), whereas the exposure to 2.5 and 
5 mM MPP+ did not result in significant decreases within 24 h (Fig. 2b). We next determined the amount of 
extracellular lactate, a product of glycolytic metabolism. During exposure to 10 and 200 μ M MPP+, significant 
increases in extracellular lactate were evident within 36 and 24 h, respectively (Fig. 2c). These results correlated 
with the extracellular glucose analysis results. In contrast, the model of acute MPP+ exposure also led to a sig-
nificant increase in extracellular lactate within 24 h; however, this result did not correlate with the extracellular 
glucose analysis results (Fig. 2b,d).
Figure 1. Differences in the toxic effects of mild and acute MPP+ exposure. (a,b) SH-SY5Y cells were 
exposed to MPP+ for up to 48 h or to 2.5 and 5 mM MPP+ for up to 24 h; cell viability at various time points was 
determined using the WST-1 assay. (c,d) Various densities of SH-SY5Y cells were exposed to 10 and 200 μ M 
MPP+ for 48 h or 2.5 and 5 mM MPP+ for 24 h, and cell viability was determined using the WST-1 assay. Data 
are expressed as means ± standard deviations (S.D.) from at least three independent experiments. *p < 0.05, 
**p < 0.01.
www.nature.com/scientificreports/
3Scientific REPORtS | 7:46668 | DOI: 10.1038/srep46668
We further investigated the effect of glucose supplementation on toxicity resulting from mild and acute MPP+ 
exposures. In brief, SH-SY5Y cells were exposed to each concentration of MPP+ and supplemented with 5.5 mM 
(1 g/L) glucose for the last 12 h. Cell death consequent to mild MPP+ exposure was significantly reduced by glu-
cose supplementation (Fig. 2e). In contrast, no significant differences were detected in the model of acute MPP+ 
exposure (Fig. 2f).
Mild MPP+-induced glucose starvation facilitates autophagosome accumulation. Autophagy 
is a lysosomal degradative process through which cytosolic constituents and damaged organelles are recycled. 
Related substrates are sequestered in double-membraned vesicles called autophagosomes, which then fuse with 
lysosomes11. We previously reported that mild MPP+ exposure induces autophagosome accumulation within 
Figure 2. Differences in energy metabolism between cells subjected to mild or acute MPP+ exposure. 
(a,b) SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ for up to 48 h or 2.5 and 5 mM MPP+ for up to 24 h; 
glucose concentrations in the culture media at several time points were measured using a commercial assay kit. 
(c,d) SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ for up to 48 h or 2.5 and 5 mM MPP+ for up to 24 h; 
extracellular lactate concentrations at several time points were measured using a commercial assay kit. (e,f) 
SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ for 48 h or 2.5 and 5 mM MPP+ for 24 h in the presence 
of 5.5 mM glucose for the last 12 h. Cell viability was determined using the WST-1 assay. Data are expressed as 
means ± S.D. from at least three independent experiments. *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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48 h as a result of impaired autophagosome degradation8. Therefore, we assessed the relationship between glucose 
starvation and autophagosome accumulation during mild MPP+ exposure. Western blot analysis revealed that 
exposure to 10 and 200 μ M MPP+ significantly increased the expression of LC3-II, an autophagosomal marker, 
within 48 h but not within 36 h (Fig. 3a), and glucose supplementation significantly suppressed the increase in 
the expression of LC3-II (Fig. 3b). Our previous report showed that mild MPP+ exposure induced the accumu-
lation of p62/SQSTM1 (p62), a selective autophagy substrate, in a 1% Nonidet P-40 (NP-40) insoluble fraction 
of lysed cells8, and we would further expect this substrate to be sequestered and aggregated in non-degraded 
autophagosomes. Furthermore, the accumulation of p62 in this insoluble fraction was also suppressed by glucose 
supplementation (Fig. 3c).
Mild MPP+ exposure enhances autophagosome synthesis. Various signalling events can enhance 
autophagy; of these, nutrient starvation (e.g. depletion of amino acids, growth factors, or glucose) is among the 
most effective enhancers of autophagosome synthesis12. Starvation-related signalling pathways converge at the 
mammalian target of rapamycin (mTOR), a central protein kinase of the nutrient-sensing pathway13. Conditions 
Figure 3. Influence of glucose supplementation on mild MPP+ exposure-induced autophagosome 
accumulation. (a) SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ for up to 48 h; LC3-II expression levels 
at several time points were detected by western blotting. (b) SH-SY5Y cells were exposed to 10 and 200 μM 
MPP+ for 48 h with or without 5.5 mM glucose for the last 12 h; LC3-II expression was detected by western 
blotting. (c) SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ for 48 h with or without 5.5 mM glucose for 
the last 12 h; p62 expression was detected by western blotting. Data are expressed as means ± S.D. from at least 
three independent experiments. *p < 0.05, **p < 0.01.
www.nature.com/scientificreports/
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of starvation enhance autophagy and thus increase energy levels by recycling cellular components, thereby 
increasing the possibility that mild MPP+-induced glucose starvation enhances autophagosome synthesis. 
Under glucose starvation, adenosine monophosphate (AMP)-activated protein kinase (AMPK) is activated by 
an increase in the AMP/adenosine triphosphate (ATP) ratio; this leads to the inactivation of mTOR, a negative 
regulator of autophagy, and thus induces autophagy14. Western blot analysis revealed that exposure to 10 and 
200 μ M MPP+ for 48 h increased the phosphorylation of AMPK, and consequently, its substrate acetyl-CoA car-
boxylase (ACC) but decreased the phosphorylation of mTOR and its target, p70 S6K. In addition, increases in 
AMPK and ACC phosphorylation were already detected within 12 h, whereas reductions in mTOR and p70 S6K 
phosphorylation were apparent 36 h onward (Figs 4a and S1a). Similar to LC3-II expression levels, these changes 
were suppressed by glucose supplementation (Fig. S1b).
To investigate enhanced autophagosome synthesis, we evaluated the turnover of LC3-II. In brief, SH-SY5Y 
cells were exposed to 10 or 200 μ M MPP+ with or without 200 nM bafilomycin A1 (Baf) for the last 4 h of expo-
sure, after which LC3-II protein expression was estimated by western blotting. Baf is a specific inhibitor of 
vacuolar-type H+-ATPase that prevents fusion between autophagosomes and lysosomes, thus preventing the 
lysosomal degradation of LC3-II. Because changes in the phosphorylation of ACC and p70 S6K were confirmed 
within 48 h, we investigated the turnover of LC3-II at various time points (24, 36 and 48 h). At 24 h, neither 10 nor 
200 μ M MPP+ exposure increased the levels of LC3-II expression, regardless of Baf treatment (Fig. 4b). However, 
exposure to 10 and 200 μ M MPP+ did not increase LC3-II expression in the absence of Baf at 36 h, although both 
concentrations increased the levels of LC3-II expression in the presence of Baf (Fig. 4c). At 48 h, exposure to 10 
and 200 μ M MPP+ increased LC3-II expression in the absence of Baf, whereas neither concentration increased 
LC3-II expression in the presence of Baf (Fig. 4d). These results suggest that mild MPP+ exposure enhances 
autophagosome synthesis within 36 h but inhibits autophagosome synthesis and autophagosome degradation 
within 48 h.
To further determine whether mild MPP+ exposure enhances autophagosome formation, we measured the 
numbers of Atg16L positive puncta at various time points via immunocytochemical analysis. During the auto-
phagic process, LC3-I, the cytosolic form of LC3, is conjugated to the membrane lipid phosphatidylethanolamine 
and converted to an autophagosome membrane-bound form (LC3-II)15. The Atg12–Atg5–Atg16L1 complex, 
which only exists in the autophagosomal precursor membrane, is necessary for the conjugation of LC3-I to 
phosphatidylethanolamine16,17.
Therefore, an increase in Atg16L-positive puncta is indicative of enhanced autophagosome biogenesis18. At 
24 h, we did not observe a significant increase in Atg16L-positive puncta in response to 10 and 200 μ M MPP+ 
(Fig. 4e). In contrast, exposure to 10 and 200 μ M MPP+ resulted in a significant increase in Atg16L-positive 
puncta at 36 h; this result, which was similar to the LC3-II turnover findings, suggested enhanced autophago-
some synthesis (Fig. 4c,f). At 48 h, although LC3-II turnover suggested that autophagosome synthesis is not 
enhanced, exposure to 10 and 200 μ M MPP+ led to significant increases in Atg16L-positive puncta (Fig. 4g). 
In the MPP+-untreated group, Atg16L-positive puncta increased in a time-dependent manner (Fig. 4e–g). 
Furthermore, a decrease in p70 S6K phosphorylation was evident in the MPP+-untreated group at 36 h and 
exacerbated at 48 h (Fig. 4a). These results suggest enhanced autophagosome synthesis in the MPP+-untreated 
group from 36 h to 48 h. Because the LC3-II turnover assay incorporates comparative evaluation between the 
MPP+-untreated group and the treated group in the presence of Baf, it might not precisely distinguish autopha-
gosome synthesis in response to mild MPP+ exposure at 48 h. Collectively, our results suggest that mild MPP+ 
exposure enhances autophagosome synthesis after 36 h.
Enhanced autophagosome synthesis contributes to toxicity associated with mild MPP+ expo-
sure. We assessed the relationship between enhanced autophagosome synthesis and toxicity associated with 
mild MPP+ exposure. Small interfering RNA (siRNA)-mediated knockdown of autophagy protein 5 (Atg5), an 
essential component of LC3 conjugation, effectively inhibited the increase in LC3-II levels in SH-SY5Y cells 
exposed to 10 or 200 μ M MPP+ for 48 h (Fig. 5a). Furthermore, the toxicity associated with exposure to 10 and 
200 μ M MPP+ for 48 h was partially reduced by Atg5 knockdown (Fig. 5b).
3-Methyladenine (3-MA), a widely used autophagy inhibitor, inhibits class III PI3K activity, an essential 
component in the induction of autophagosome synthesis. Notably, because 3-MA is usually used at very high 
concentrations for autophagy inhibition, other kinases and cellular processes may be affected19–21. To minimise 
these effects, SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ with or without 5 mM 3-MA for only the last 
24 h. 3-MA also inhibited the increase in LC3-II and attenuated the toxicity associated with 10 and 200 μ M MPP+ 
exposure (Fig. 5c,d). Moreover, autophagy inhibition did not significantly increase the amount of glucose in the 
culture medium (Fig. S2). Taken together, our data suggest that enhanced autophagosome synthesis is involved in 
the toxicity associated with mild MPP+ exposure.
Discussion
MPP+ is selectively assimilated by dopaminergic neurons and inhibits complex I of the mitochondrial ETC9. It 
is reported that MPP+ toxicity occurs simultaneously with reductions in phosphocreatine and ATP as well as 
increases in lactic acid and glucose utilisation in different cultures, including neuroblastoma, primary neuron 
and rat brain slice10,22–24. In addition, supplementation of glucose, a major energy source for the brain, has been 
reported to prevent MPP+ toxicity and ATP reduction by increasing anaerobic glycolysis activity25–28. In the pres-
ent study, we revealed that mild MPP+ exposure induced glucose starvation and led to cell death, whereas acute 
MPP+ exposure led to glucose starvation-independent cell death. During mild MPP+ exposure, we observed the 
onset of cell death with simultaneous glucose depletion (Figs 1a and 2a). Moreover, cell death was significantly 
suppressed by glucose supplementation, even at 36 h after mild MPP+ exposure (Fig. 2e). These results imply that 
mild MPP+ exposure induces cell death through glucose starvation and the subsequent lack of energy.
www.nature.com/scientificreports/
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We previously reported that exposure to 10 μ M MPP+ induced the accumulation of α -syn within 48 h8, and 
glucose starvation was also reported to induce the accumulation of α -syn in mouse primary mesencephalic 
Figure 4. Time-dependent changes in autophagic induction with mild MPP+ exposure. (a) SH-SY5Y cells 
were exposed to 10 and 200 μ M MPP+ for up to 48 h. Time-dependent changes in the phosphorylation levels 
of various proteins were estimated by western blotting. (b,c,d) SH-SY5Y cells were exposed to 10 and 200 μM 
MPP+ for 24 h (b), 36 h (c) or 48 h (d) with or without 200 nM bafilomycin A1 (Baf) for the last 4 h; LC3-II 
turnover was estimated by western blotting at various time points. (e,f,g) SH-SY5Y cells were exposed to 10 and 
200 μ M MPP+ for 24 h (e), 36 h (f) or 48 h (g) and subsequently immunostained with an anti-Atg16L antibody. 
The numbers of Atg16L-positive puncta per cell were evaluated at various time points. Data are expressed as 
means ± S.D. from at least three independent experiments. **p < 0.01.
www.nature.com/scientificreports/
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neurons29. Both enhanced glycolytic activity and accumulation of α -syn in the brain were confirmed in a chronic 
MPTP mouse model produced using a continuous minipump infusion system30. Thus, mild MPP+ exposure 
may reflect the chronic MPTP mouse model. It is also reported that mutation of PD-related genes which relate to 
quality control of mitochondria induce enhanced glycolytic activity and accumulation of α -syn. Parkin-mutant 
Drosophila larvae exhibited defective locomotion with a bradykinesia-like phenotype and showed reduced oxy-
gen and ATP concentrations and an increased lactate concentration31. Parkin knockdown and knockout activates 
glycolysis and reduces mitochondrial respiration in cultured cells32. Glycolysis is also enhanced by the knockout 
of two other PD-related genes, PTEN-induced putative kinase 1 (PINK1) and DJ-133–36. Moreover, both PINK1 
and DJ-1 associated with the accumulation of α -syn37,38.
Acute MPP+ exposure did not significantly alter the amount of glucose in the culture medium within 24 h 
(Fig. 2b). If acute MPP+ exposure does not facilitate the glucose consumption, a reduction in the amount of glu-
cose in the culture medium progresses more slowly than that in the amount of glucose in the MPP+-untreated 
group because of the reduced number of living cells. Therefore, these data implicate that acute MPP+ exposure 
enhances glycolytic activity (Figs 1a and 2b). However, cell death occurred even when sufficient glucose was 
retained in the culture medium (Figs 1b and 2b). Moreover, glucose supplementation did not alleviate acute 
MPP+-induced cell death (Fig. 2f). These results suggest that the model of acute MPP+ exposure induces many 
events, other than glucose starvation, that are essential for cell death. Although the amount of glucose in the 
medium did not significantly decrease within 24 h of acute MPP+ exposure, extracellular lactate levels signifi-
cantly increased within the same period (Fig. 2b,d). α -Ketoglutarate dehydrogenase (α -KGDH), an enzyme in the 
tricarboxylic acid (TCA) cycle, is also inhibited by MPP+ in a concentration-dependent manner39,40. Therefore, 
acute MPP+ exposure might strongly suppress TCA cycle activity through α -KGDH inhibition, leading to an 
increase in extracellular lactate levels.
The presence of Lewy bodies or abnormal protein aggregates has been confirmed in patients with PD, 
dementia with Lewy bodies and other diseases, and both LC3 and p62 have been identified in Lewy bod-
ies from patients’ brains41–43. These reports imply a relationship between abnormal autophagy and Lewy body 
formation. Several groups have reported that MPP+ exposure increases the number of autophagosomes in cell 
cultures. However, consensus has yet to be reached regarding the proposed mechanism underlying this phe-
nomenon because some studies suggest enhanced autophagosome synthesis44–47 and others report impaired 
Figure 5. Influence of autophagy inhibition on toxicity associated with mild MPP+ exposure. (a) SH-SY5Y 
cells were transfected with siRNA specific for autophagy protein 5 (siAtg5) or scrambled control siRNA for 24 h 
and subsequently exposed to 10 and 200 μ M MPP+ for 48 h. LC3-II and Atg5 expression levels were analysed by 
western blotting. (b) SH-SY5Y cells were transfected with siAtg5 or scrambled control siRNA for 24 h, followed 
by exposure to 10 and 200 μ M MPP+ for 48 h. Cell viability was determined by a WST-1 assay. (c) SH-SY5Y cells 
were exposed to 10 and 200 μ M MPP+ for 48 h with or without 5 mM 3-MA for the last 24 h; LC3-II expression 
was analysed by western blotting. (d) SH-SY5Y cells were exposed to 10 and 200 μ M MPP+ for 48 h with or 
without 5 mM 3-MA for the last 24 h; cell viability was determined by the WST-1 assay. Data are expressed as 
the means ± S.D. from at least three independent experiments.
www.nature.com/scientificreports/
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autophagosome degradation48,49. This discrepancy implies that the effects of MPP+ exposure on the autophagic 
process vary depending on the exposure condition and/or cell type. In the present study, we revealed glucose 
starvation to be the cause of impaired autophagosome degradation during mild MPP+ exposure (Fig. 3). We fur-
ther suggest that mild MPP+ exposure enhances autophagosome synthesis via glucose starvation (Figs 4 and S1). 
Although we did not detect an increase in LC3-II expression levels in SH-SY5Y cells exposed to mild MPP+ 
within 36 h (Fig. 3a), our results shown in Fig. 4 suggested that autophagosome synthesis was already enhanced 
at 36 h. SH-SY5Y cells were previously found to exhibit minimal increases in LC3-II after nutrient deprivation, 
despite enhanced autophagosome synthesis, whereas treatment with a lysosomal inhibitor or autophagosome 
fusion inhibitor facilitates the detection of increased levels of LC3-II50,51, likely because of high basal autophagic 
flux in cells of neuronal origin52,53. Mature neurons cannot dissipate intracellular protein aggregates through cell 
division; therefore, autophagic quality control of intracellular proteins is crucial for neuronal survival54. Indeed, 
brain-specific autophagy-deficient mice exhibited protein aggregate formation, neuronal cell death and neuro-
degenerative disorder-like symptoms55,56. However, our data showed that the suppression of autophagosome 
synthesis alleviated mild MPP+-induced cell death. Inhibition of autophagosome synthesis did not significantly 
affect the cellular glucose consumption (Fig. S2). Therefore, Enhanced synthesis under the conditions of impaired 
autophagosome degradation might facilitate autophagosome accumulation, thus disrupting intracellular pro-
tein quality control. Zhu et al. investigated the toxicity associated with chronic MPP+ exposure and suggested 
the presence of enhanced autophagosome synthesis via extracellular signal-regulated protein kinases (ERK)57. 
Moreover, these authors suggested that the suppression of autophagosome synthesis reduced cell death. Because 
glucose starvation increases the levels of reactive oxygen, thereby enhancing autophagosome synthesis via p38 
mitogen-activated protein kinases, c-Jun N-terminal protein kinase, or ERK14, our mild MPP+ exposure model 
also likely upregulates ERK through glucose starvation. On the other hand, Zhu et al. confirmed the presence of 
enhanced autophagosome synthesis but not impaired autophagosome degradation57. Therefore, both phenomena 
might have occurred in their chronic model.
In summary, mild MPP+ exposure induced cell death through glucose starvation, accelerated non-degraded 
autophagosome accumulation correlates with cell death and toxicity associated with mild MPP+ exposure differs 
from that associated with acute MPP+ exposure. The present study might reveal the relationship between abnor-
mal glucose metabolism and dysfunctional autophagic machinery in PD.
Methods
Chemicals. MPP+ iodide and 3-Methladenine were purchased from Sigma-Aldrich, D-(+ )-Glucose from 
Wako, Bafilomycin A1 from Cayman chemical.
Cell cultutre. Human neuroblastoma SH-SY5Y cells were purchased from American Type Culture Collection 
(ATCC, CRL-2266). The cells were grown in Dulbecco’s modified eagle medium (low-glucose) supplemented 
with 0.854 g/L L-glutamine, 5% fetal bovine serum, 5% horse serum, and 0.2% sodium hydrogen carbonate 
under a humidified atmosphere of 95% air-5% CO2 at 37 °C. For experiments, cells were seeded at a density of 
6.04 × 104 cells/174 μ L/cm2 and incubated overnight. The medium was changed just before MPP+ treatment in 
all experiments.
Cell viability analysis. Cell viability was measured with the water-soluble tetrazolium salt (WST)-1 assay. 
The cells were seeded in 96-well plate, incubated overnight. After treatment, cells were incubated for 1 h at 37 °C 
with a mixed solution of WST-1, 1-methoxy-5-methylphenazinium methylsulfate, and DMEM. The absorbance 
of the converted dye was measured at 415 nm using a MultiSkan Go microplate spectrophotometer (Thermo 
Fisher Scientific).
Glucose assay. Glucose in the culture medium was evaluated using the Glucose colorimetric/fluorometric 
assay kit (Bio Vision, K606-100) according to the manufacture’s instructions. Briefly, cells were seeded in a 24-well 
plate, incubated overnight, and treated with MPP+. The culture medium were collected and then centrifuged at 
400× g for 5 min at 4 °C. Aliquot of supernatant from each samples was added to the reaction solution and incu-
bated for 30 min at 37 °C. The absorbance at 570 nm was measured with a plate reader.
Glycolytic activity assay. Glycolytic activity was determined by measuring the amount of L-lactate, the 
end product of glycolysis. The activity was measured using glycolysis cell-based assay kit (Cayman chemical, 
600450) according to the product manual. Briefly, cells were seeded in a 96-well plate, incubated overnight, and 
treated with MPP+. The culture medium were collected and then centrifuged at 400× g for 5 min at 4 °C. Aliquot 
of supernatant from each samples was added to the reaction solution and incubated with gentle shaking on an 
orbital shaker for 30 min. The absorbance at 490 nm was measured with a plate reader.
1% NP-40-soluble and –insoluble fraction. The cells were seeded in 60-mm dish, incubated overnight, 
and treated with MPP+. After treatment cells were washed three times with PBS(− ), then lysed with TNE buffer 
containing 1% Nonidet P-40 [20 mM Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1 mM 
sodium fluoride, 1 mM sodium orthovanadate, 1% protease inhibitor cocktail]. The cell lysates were sonicated on 
ice, rotated for 30 min at 4 °C, and centrifuged at 22,000× g for 20 min at 4 °C. The supernatants were collected as 
1% Nonidet P-40-soluble fractions. Then, the pellets were further lysed in TNE buffer containing 2% SDS [20 mM 
Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% SDS, 1 mM sodium fluoride, 1 mM sodium orthovanadate, 
1% protease inhibitor cocktail], sonicated on ice, rotated for 30 min at room temperature (RT), and collected as 
1% Nonidet P-40-insoluble fractions. Protein concentration of each sample extract was determined with Pierce 
BCA Protein Assay Kit (Thermo Fisher Scientific, 23227). Cell lysates were heated with Laemmli’s sample buffer 
at 95 °C for 5 min.
www.nature.com/scientificreports/
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Immunoblot analysis. Equivalent amounts of protein (5–20 μ g) from each sample were loaded and sepa-
rated on SDS-PAGE, then transferred to a PVDF membrane. Membranes were blocked with 5% skim milk in TBS 
supplemented with 0.1% Tween 20 (TBS-T) for 1 h at RT. The membranes were probed with anti-LC3 anti body 
(MBL, PM036), anti-p62/SQSTM1 antibody (MBL, M162-3), anti-phospho-AMPK α (Thr172) (Cell Signaling, 
#2535), anti-AMPK α (Cell Signaling, #2532), anti-phospho-ACC (Ser79) (Cell signaling, #3661), anti-ACC 
(Cell Signaling, #3662), anti-phospho-mTOR (Ser2448) (Cell signaling, #5536), anti-mTOR (Cell Signaling, 
#2972), anti-phospho-p70 S6K (T421/S424) (R&D Systems, AF8965), anti-p70 S6K (R&D Systems, AF8962), 
anti-Atg5 (MBL, PM050), or anti-β -actin antibody (Sigma-Aldrich, A5441) diluted in 5% skim milk or Can Get 
Signal® Immunoreaction Enhancer Solution (TOYOBO) for 2 h at RT or overnight at 4 °C. After washing with 
TBS-T three times, membranes were probed with HRP-conjugated goat anti-rabbit IgG antibody (Sigma-Aldrich, 
A9169) or HRP-conjugated anti-mouse IgG antibody (Sigma-Aldrich, A9044) for 1 h at RT. After washing with 
TBS-T three times, membranes were incubated Chemi-Lumi One L (Nacalai Tesque) or Chemi-Lumi One Ultra 
(Nacalai Tesque). Specific bands were detected using a luminescent image analyzer (GE Healthcare, ImageQuant 
LAS 4000); relative band intensities were quantified by densitometric analysis using Image J.
Immunocytochemical analyses. SH-SY5Y cells were seeded in poly-d-lysine-coated four-well chamber 
slides (BD Biosciences, 354577) and incubated overnight at 37 °C in a humidified 5% CO2 incubator. Cells were 
exposed to MPP+ as indicated, washed with PBS(− ), and fixed with 4% paraformaldehyde in PBS(− ) for 10 min 
at RT. Fixed cells were washed with PBS(− ), permeabilized twice with PBS(− ) containing 0.1% triton X-100 
(PBS-Tx) for 15 min at RT, blocked with 3% BSA in PBS-Tx for 1 h, and incubated with a rabbit anti-Atg16L anti-
body (MBL, PM040) diluted in PBS-Tx for 2 h for RT. Labeled cells were then washed three times with PBS-Tx, 
incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG (Life Technologies, A11008) diluted in PBS-Tx 
for 1 h at RT in the dark, washed three times with PBS(− ), incubated with 600 nM DAPI (Life Technologies, 
D1306) in PBS(− ) for 5 min at RT in the dark, washed twice in PBS(− ), and mounted in Prolong Diamond anti-
fade reagent (Life Technologies, P36961). After incubation overnight, slides were observed under a confocal laser 
scanning microscope (Olympus, FV1000-D IX81). Images were processed using ImageJ software. Graph: Average 
number of Atg16L-positive puncta per cell. At least n = 10 fields with at least 100 cells per condition from three 
independent experiments.
RNA interference. Silencing of Atg5 was performed with siAtg5 (Ambion, s18158 and s18160) or scrambled 
control (Ambion, AM4611). Transfection of siRNAs (10 nM) was performed using Lipofectamine RNAiMAX 
Transfection Reagent (Thermo Fisher Scientific) according to the manufacture’s protocol. 24 h after transfection, 
cells were transferred into the appropriate plate or dish for experiments.
Statistical analysis. Data are expressed as the mean ± standard deviations (S.D.) from at least three 
independent experiments. Significant differences between multiple independent groups were determined by 
Tukey-Kramer test with probability value (p) < 0.05 considered significant.
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